Current Neuro-Oncology
Volume
25 Number 9
15 May 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 9, 15 May
Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY,
Gomez C, Bebawy JF, Liu BP, Bouchoux G, Desseaux C, Helenowski IB,
Lukas RV, Dixit K, Kumthekar P, Arrieta VA, Lesniak MS, Carpentier
A, Zhang H, Muzzio M, Canney M, Stupp R.
Repeated
blood-brain barrier opening with an implantable ultrasound device
for delivery of albumin-bound paclitaxel in patients with
recurrent glioblastoma: a phase 1 trial.
Lancet
Oncol. 2023 May;24(5):509-522∟.
doi: 10.1016/S1470-2045(23)00112-2∟.
PMID: 37142373∟.
Interventional study˰ ˍ
Wang GB, Wang WX, Luo JJ.
Clinical
effectiveness of sodium fluorescein-guided microsurgery in
patients with high-grade gliomas.
Eur
Rev Med Pharmacol Sci. 2023 May;27(9):3906-3913∟.
doi: 10.26355/eurrev_202305_32296∟.
PMID: 37203814∟.
Observational study. ˍ
Anvari K, Shahabadi M, Welsh JS, Javadinia SA, Zarei E.
Outcome
of Second Line Treatment of Recurrent High- Grade Glioma by
re-Irradiation or Bevacizumab-based Chemotherapy: A Cross
Sectional Study.
Asian
Pac J Cancer Prev. 2023 May 1;24(5):1507-1511∟.
doi: 10.31557/APJCP.2023.24.5.1507∟.
PMID: 37247269∟.
Observational study. ˍ
Das A, Tabori U, Sambira Nahum LC, Collins NB, Deyell R, Dvir R,
Faure-Conter C, Hassall TE, Minturn JE, Edwards M, Brookes E,
Bianchi V, Levine A, Stone SC, Sudhaman S, Sanchez-Ramirez S,
Ercan AB, Stengs L, Chung J, Negm L, Getz G, Maruvka YE,
Ertl-Wagner B, Ohashi PS, Pugh T, Hawkins C, Bouffet E,
Morgenstern DA.
Efficacy of nivolumab
in pediatric cancers with high mutation burden and mismatch-repair
deficiency.
Clin Cancer
Res. 2023 May 1:CCR-23-0411∟.
doi: 10.1158/1078-0432.CCR-23-0411∟.
PMID: 37126021∟.
Interventional study. ˍ
Warren KE, Vezina G, Krailo M, Springer L, Buxton A, Peer CJ, Figg
WD, William-Hughes C, Kessel S, Fouladi M, Gajjar A, Bowers
D.
Phase II Randomized Trial of
Lenalidomide in Children With Pilocytic Astrocytomas and Optic
Pathway Gliomas: A Report From the Children's Oncology Group.
J
Clin Oncol. 2023 May 1:JCO2201777∟.
doi: 10.1200/JCO.22.01777∟.
PMID: 37126770∟.
Interventional study˰ ˍ
Drexler R, Sauvigny T, Schüller
U, Eckhardt A, Maire CL, Khatri R, Hausmann F, Hänzelmann S,
Huber TB, Bonn S, Bode H, Lamszus K, Westphal M, Dührsen L,
Ricklefs FL.
Epigenetic
profiling reveals a strong association between lack of 5-ALA
fluorescence and EGFR
amplification
in IDH-wildtype
glioblastoma.
Neurooncol
Pract. 2023 May 2;10(5):462-471∟.
doi: 10.1093/nop/npad025∟.
PMID: 37720395∟.
Observational study˰ ˍ
Hu P, Xu L, Qi Y, Yan T, Ye L, Wen
S, Yuan D, Zhu X, Deng S, Liu X, Xu P, You R, Wang D, Liang S, Wu
Y, Xu Y, Sun Q, Du S, Yuan Y, Deng G, Cheng J, Zhang D, Chen Q,
Zhu X.
Combination
of multi-modal MRI radiomics and liquid biopsy technique for
preoperatively non-invasive diagnosis of glioma based on deep
learning: protocol for a double-center, ambispective, diagnostical
observational study.
Front
Mol Neurosci. 2023 May 2;16:1183032∟.
doi: 10.3389/fnmol.2023.1183032∟.
PMID: 37201155∟.
Interventional study protocol. ˍ
Wu X, Alvarez-Breckenridge C.
Moving
the Pendulum for Glioblastoma Treatment: One Injection at a
Time.
Oncologist. 2023
May 2:oyad104∟.
doi: 10.1093/oncolo/oyad104∟.
PMID: 37130338∟.
Comment. ˍ
REFERS
TO: Todo
T, et al., Intratumoral
oncolytic herpes virus G47∆ for residual or recurrent
glioblastoma: a phase 2 trial.
Nat
Med. 2022 Jul 21∟.
doi: 10.1038/s41591-022-01897-x∟.
PMID: 35864254∟.
Interventional study. ˍ
Zhang M, Xiao X, Gu G, Zhang P, Wu
W, Wang Y, Pan C, Wang L, Li H, Wu Z, Zhang J, Zhang L.
Role
of neuronavigation in the surgical management of brainstem
gliomas.
Front
Oncol. 2023 May 2;13:1159230∟.
doi: 10.3389/fonc.2023.1159230∟.
PMID: 37205194∟.
Observational study. ˍ
Krishna S, Choudhury A, Keough MB,
Seo K, Ni L, Kakaizada S, Lee A, Aabedi A, Popova G, Lipkin B, Cao
C, Nava Gonzales C, Sudharshan R, Egladyous A, Almeida N, Zhang Y,
Molinaro AM, Venkatesh HS, Daniel AGS, Shamardani K, Hyer J, Chang
EF, Findlay A, Phillips JJ, Nagarajan S, Raleigh DR, Brang D,
Monje M, Hervey-Jumper SL.
Glioblastoma
remodelling of human neural circuits decreases survival.
Nature.
2023 May 3;617(7961):599-607∟.
doi: 10.1038/s41586-023-06036-1∟.
PMID: 37138086∟.
Laboratory investigation. ˍ
Ho C, Malicki D, Levy M, Crawford JR.
Unusual
pattern of metastatic disease in a patient in their early
childhood with group 4 medulloblastoma.
BMJ
Case Rep. 2023 May 4;16(5):e253877∟.
doi: 10.1136/bcr-2022-253877∟.
PMID: 37142287∟.
Case
report. ˍ
Chen W, Jin S, Liu Q, Wang H, Xia
Y, Guo X, Guo S, Wang Y, Shi Y, Liu D, Li Y, Wang Y, Xing H, Li J,
Wu J, Liang T, Qu T, Li H, Yang T, Zhang K, Wang Y, Ma
W.
Spotlights
on adult patients with pediatric-type diffuse gliomas in
accordance with the 2021 WHO classification of CNS tumors.
Front
Neurosci. 2023 May 5;17:1144559∟.
doi: 10.3389/fnins.2023.1144559∟.
PMID: 37214395∟.
Observational study. ˍ
Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A,
Yadavilli S, Parackal S, Game S, Chong WC, Jayasekara WSN, Le
Grand M, Kearney PS, Douglas AM, Findlay IJ, Germon ZP, McEwen HP,
Beitaki TS, Patabendige A, Skerrett-Byrne DA, Nixon B, Smith ND,
Day B, Manoharan N, Nagabushan S, Hansford JR, Govender D,
McCowage GB, Firestein R, Howlett M, Endersby R, Gottardo NG,
Alvaro F, Waszak SM, Larsen MR, Colino-Sanguino Y, Valdés-Mora
F, Rakotomalala A, Meignan S, Pasquier E, Andre N, Hulleman E,
Eisenstat DD, Vitanza NA, Nazarian J, Koschmann C, Mueller S, Cain
JE, Dun MD.
ONC201 in combination with
paxalisib for the treatment of H3K27-altered diffuse midline
glioma.
Cancer Res.
2023 May 5:CAN-23-0186∟.
doi: 10.1158/0008-5472.CAN-23-0186∟.
PMID: 37145169∟.
Interventional
study. ˍ
Burger MC, Forster MT, Romanski A, Straßheimer F, Macas J,
Zeiner PS, Steidl E, Herkt S, Weber KJ, Schupp J, Lun JH, Strecker
MI, Wlotzka K, Cakmak P, Opitz C, George R, Mildenberger IC,
Nowakowska P, Zhang C, Röder J, Müller E, Ihrig K,
Langen KJ, Rieger MA, Herrmann E, Bönig H, Harter PN, Reiss
Y, Hattingen E, Rödel F, Plate KH, Tonn T, Senft C, Steinbach
JP, Wels WS.
Intracranial injection of
NK cells engineered with a HER2-targeted chimeric antigen receptor
in patients with recurrent glioblastoma.
Neuro
Oncol. 2023 May 6:noad087∟.
doi: 10.1093/neuonc/noad087∟.
PMID: 37148198∟.
Interventional
study. ˍ
Neagu A, Niculae CM, Lăpădat I, Hristea A.
Challenges
in the diagnosis of leptomeningeal dissemination of glioblastoma
in a patient with fever and xanthochromic CSF: a case report.
Rom
J Intern Med. 2023 May 6∟.
doi: 10.2478/rjim-2023-0010∟.
PMID: 37148304∟.
Case
report. ˍ
Hertler C, Felsberg J, Gramatzki D, Le Rhun E, Clarke J, Soffietti
R, Wick W, Chinot O, Ducray F, Roth P, McDonald K, Hau P,
Hottinger AF, Reijneveld J, Schnell O, Marosi C, Glantz M, Darlix
A, Lombardi G, Krex D, Glas M, Reardon DA, van den Bent M, Lefranc
F, Herrlinger U, Razis E, Carpentier AF, Phillips S, Rudà
R, Wick A, Tabouret E, Meyronet D, Maurage CA, Rushing E, Rapkins
R, Bumes E, Hegi M, Weyerbrock A, Aregawi D, Gonzalez-Gomez C,
Pellerino A, Klein M, Preusser M, Bendszus M, Golfinopoulos V, von
Deimling A, Gorlia T, Wen PY, Reifenberger G, Weller M.
Long-term
survival with IDH wildtype glioblastoma: first results from the
ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC
1419).
Eur J Cancer.
2023 May 8:S0959-8049(23)00230-7∟.
doi: 10.1016/j.ejca.2023.05.002∟.
PMID: 37277265∟.
Observational study. ˍ
Sozer A, Borcek AO, Sagiroglu S, Poshtkouh A, Demirtas Z,
Karaaslan MM, Kuzucu P, Celtikci E.
The
first case of glioma detected by an artificial intelligence
algorithm running on real-time data in neurosurgery: illustrative
case.
J Neurosurg Case
Lessons. 2023 May 8;5(19):CASE22536∟.
doi: 10.3171/CASE22536? PMID:
37158388∟.
Case report. ˍ
Zohdy YM, Agam M, Maldonado J, Jahangiri A, Pradilla G,
Garzon-Muvdi T.
Symptomatic
intracranial tumors in pregnancy: an updated management algorithm.
Illustrative case.
J
Neurosurg Case Lessons. 2023 May 8;5(19):CASE2399∟.
doi: 10.3171/CASE2399?
PMID: 37158391∟.
Case report. ˍ
Alimohamadi M, Pour-Rashidi A, Larijani A, Rahmani M, Hendi K,
Shariat Moharari R, Raminfard S, Ajam H, Gerganov V.
Perioperative
seizure in patients undergoing brain mapping under awake
craniotomy for language-related eloquent region gliomas: a
prospective study.
J
Neurosurg Sci. 2023 May 9∟.
doi: 10.23736/S0390-5616.22.05675-2∟.
PMID: 37158710∟.
Interventional study˰ ˍ
Semeraro M, Fouquet C, Vial Y, Amiel J, Galmiche L, Cretolle C,
Blanc T, Jolaine V, Garcelon N, Entz-Werle N, Pellier I, Vérité
C, SophieTaque, Coulomb A, Petit A, Corradini N, Bouazza N, Lacour
B, Clavel J, Brugières L, Bourdeaut F, Sarnacki S; members
of the TED consortium.
Pediatric Tumors
and Developmental Anomalies: A French Nationwide Cohort Study.
J
Pediatr. 2023 May 9:113451∟.
doi: 10.1016/j.jpeds.2023.113451∟.
PMID: 37169337∟.
Observational
study˰ ˍ
Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ,
Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM,
Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow
JE, Kizilbash SH, Tortorelli S, Burns TC.
Cerebrospinal
fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant
gliomas.
Neurooncol
Adv. 2023 May 11;5(1):vdad061∟.
doi: 10.1093/noajnl/vdad061∟.
PMID: 37313502∟.
Interventional study. ˍ
Blobner J, Dengler L, Blobner S, Eberle C, Weller J, Teske N,
Karschnia P, Rühlmann K, Heinrich K, Ziemann F, Greif PA,
Jeremias I, Wuerstlein R, Hasselmann K, Dorostkar M, Harter PN,
Quach S, Stoecklein V, Albert NL, Niyazi M, Tonn JC, Thon N,
Christoph Westphalen B, von Baumgarten L.
Significance
of molecular diagnostics for therapeutic decision-making in
recurrent glioma.
Neurooncol
Adv. 2023 May 12;5(1):vdad060∟.
doi: 10.1093/noajnl/vdad060∟.
PMID: 37287694∟.
Observational study. ˍ
*
Ranjan T, Yu A, Elhamdani S, Howard CM, Lirette ST, Denning KL,
Valluri J, Claudio PP.
Treatment of
unmethylated MGMT-promoter recurrent glioblastoma with cancer stem
cell assay-guided chemotherapy and the impact on patients'
healthcare costs.
Neurooncol
Adv. 2023 May 12;5(1):vdad055∟.
doi: 10.1093/noajnl/vdad055∟.
PMID: 37287692∟.
Observational study. ˍ
Wang R, Cui J, Diao Y, Jin C, Chen Y, Lv X, Li X.
Risk
factor analysis and nomogram establishment and verification of
brain astrocytoma patients based on SEER database.
Sci
Rep. 2023 May 12;13(1):7754∟.
doi: 10.1038/s41598-023-33537-w∟.
PMID: 37173353∟.
Observational
study. ˍ
Yu X, Hong W, Ye M, Lai M, Shi C,
Li L, Ye K, Xu J, Ai R, Shan C, Cai L, Luo L.
Atypical
primary central nervous system lymphoma and glioblastoma:
multiparametric differentiation based on non-enhancing volume,
apparent diffusion coefficient, and arterial spin labeling.
Eur
Radiol. 2023 May 12∟.
doi: 10.1007/s00330-023-09681-2∟.
PMID: 37171492∟.
Observational study. ˍ
Zilioli A, Misirocchi F, Mutti C, Pancaldi B, Mannini E, Spallazzi
M, Parrino L, Cerasti D, Michiara M, Florindo I.
Volumetric
hippocampal changes in glioblastoma: a biomarker for
neuroplasticity?
J
Neurooncol. 2023 May 13∟.
doi: 10.1007/s11060-023-04315-5∟.
PMID: 37178276∟.
Observational
study. ˍ
Al-Romaihi N, Awadh M, Albalooshi M, Ahmed M, Darwish
A.
Clinicopathological and
Immunohistochemistry Study of a Long Survivor of Giant Cell
Glioblastoma in a Patient With Neurofibromatosis 1: Case
Report.
Cureus. 2023
May 14;15(5):e39014∟.
doi: 10.7759/cureus.39014∟.
PMID: 37323350∟.
Case report. ˍ
Oblitas López S, Bocanegra-Becerra JE, Castillo-Huerta NM,
Ludeña-Esquivel A, Becerra Zegarra A.
Awake
Craniotomy for Resection of Diffuse Astrocytoma During Pregnancy:
A Case Report.
Cureus.
2023 May 14;15(5):e39016∟.
doi: 10.7759/cureus.39016∟.
PMID: 37378163∟.
Case report. ˍ
Knight A, Horsley P, Yuile A, Yim
J, Suh M, Venketesha V, Kastelan M, Wheeler H, Back M.
Volumetric
response and pattern of failure of histone altered high grade
glioma in adults following management with radiation therapy.
J
Neurooncol. 2023 May 15∟.
doi: 10.1007/s11060-023-04332-4∟.
PMID: 37184742∟.
Observational study˰ ˍ
Nassiri F, Patil V, Yefet LS, Singh
O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H,
Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R,
Vogelbaum MA, Khagi S, Kaley T, Melear JM, Peereboom DM, Rodriguez
A, Yankelevich M, Nair SG, Puduvalli VK, Aldape K, Gao A,
López-Janeiro Á, de Andrea CE, Alonso MM, Boutros P,
Robbins J, Mason WP, Sonabend AM, Stupp R, Fueyo J, Gomez-Manzano
C, Lang FF, Zadeh G.
Oncolytic
DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma:
a phase 1/2 trial.
Nat
Med. 2023 May 15∟.
doi: 10.1038/s41591-023-02347-y∟.
PMID: 37188783∟.
Interventional study. ˍ
Tuleasca C, Leroy HA, Strachowski
O, Derre B, Maurage CA, Peciu-Florianu I, Reyns N.
Combined
use of intraoperative MRI and awake tailored microsurgical
resection to respect functional neural networks: preliminary
experience.
Swiss
Med Wkly. 2023 May 15;153:40072∟.
doi: 10.57187/smw.2023.40072∟.
PMID: 37192405∟.
Observational study. ˍ
Zakharova NE, Batalov AI, Pogosbekian EL, Chekhonin IV, Goryaynov
SA, Bykanov AE, Tyurina AN, Galstyan SA, Nikitin PV, Fadeeva LM,
Usachev DY, Pronin IN.
Perifocal Zone
of Brain Gliomas: Application of Diffusion Kurtosis and Perfusion
MRI Values for Tumor Invasion Border Determination.
Cancers
(Basel). 2023 May 15;15(10):2760∟.
doi: 10.3390/cancers15102760∟.
PMID: 37345097∟.
Observational study. ˍ